Open original FDA record ↗Recall record
- FDA identifier
- Z-2725-2026
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Jul 10, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject properly, fluid leakage, or separation of the syringe from the system, potentially requiring device exchange and prolonging the procedure.
Source facts
- Action
- On June 30, 2026, the firm began notifying US customers via letters titled "Urgent Medical Device Removal - Immediate Action Required." Customers were instructed to immediately stop further use or distribution of affected product, and segregate it. Continue to follow the standard care when monitoring patients treated with the contact. Product is to be returned to Boston Scientific.
- Initiated
- 2026-06-30
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution. OUS consignee list pending.
- Recall number
- Z-2725-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221336
- FDA classified
- 2026-07-10
- Recall event number
- 99336